|
Clearing The Air On The Sanofi-Regeneron Asthma Drug Trial
Seeking Alpha Results announced this week of a clinical trial testing the drug dupilumab, made by the biotechnology company Regeneron Pharmaceuticals (REGN) and global pharmaceutical company Sanofi (SNY) gave hope to asthma sufferers and got the attention of … |
View full post on asthma – Google News